Commercialization: Page 66
-
Minding the As & Qs of Lead Gen Technology
Augmented reality (AR) may sound new, but actually it has been around for at least 10 years, reports say, and it is the recent uptake in smartphone use and capability, along with funding from the Recovery Act, that have pushed AR to the front and center of pharma marketing plans. Using a smartpho...
By Robin Robinson • March 28, 2011 -
Uncovering the Value of Late-Phase Trials
Finding Added Value in Late-Phase Research Postapproval studies are becoming bigger and more expensive. As a result, pharmaceutical sponsors are looking at other ways to use the data generated from these studies to create value for their organizations. Postmarketing studies are becoming increas...
By PharmaVoice Team • March 28, 2011 -
Last Word
PV: What are some ways pharmaceutical companies can use social media to reach patients? Gupta: The key benefit for pharmaceutical companies is to better understand the patient’s perspective. For many illnesses, especially chronic diseases, patients face many issues beyond the actual medication, ...
By PharmaVoice Team • March 28, 2011 -
Talent Pool
Pharmaceutical POOL Steve FRY Dr. Sue MAHONY Lilly Announces Leadership Shifts Lilly has promoted Steve Fry to senior VP of human resources and diversity. Mr. Fry was previously VP of human resources for two of Lilly’s business areas, biomedicines and emerging markets. Mr. Fry succeeds Sue Mahony...
By PharmaVoice Team • March 28, 2011 -
Social Media
In January, Sanofi-Aventis surprised the industry by launching the first ever pharma blog — Discuss Diabetes — that encourages a two-way communication with diabetes patients. According to Laura Kolodjeski, senior manager, U.S. Diabetes Patient Solutions and blog curator, sanofi-aventis views soci...
By PharmaVoice Team • March 28, 2011 -
Tools of the Trade
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: Tufts Institute Seeks to Increase Biopharma Partnerships Contracting Module Reduces Study Cycle Time In other technology news… E-UPGRADES AND ENHANCEMENTS The Tufts Institute for Biomedical Partnerships is a glob...
By PharmaVoice Team • March 28, 2011 -
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Pharma Faces Record Patent Expirations Sidebars: Projected U.S. sales of top products going off patent in 2011 Projected U.S. sales of top products going off patent in 2012 New Product Planning Team Key to Launch Success...
By PharmaVoice Team • March 28, 2011 -
Ready to Take a Risk Again?
As agencies, we share a responsibility to experiment and push boundaries to drive our brands’ — and our Clients — success. Media channels and offerings are varied and increasing every day. The potential for innovation within the digital media sphere is such that you can create what you need versu...
By Tatiana Lyons SVP • March 7, 2011 -
What Advances in Technology did to Healthcare Communications
Welcome to the 21st century — a time period where advances in electronic media have opened new opportunities to communicate with physicians and patients, explore creativity, and help bring the health care world closer together. But as we’ll see, there are some things in our business that even th...
By Barclay Missen • March 7, 2011 -
Reach More Potential Patients
In the year ending October 2010, more than $4.4 billion was spent to promote drugs directly to consumers (DTC) through television, magazine, newspaper, Internet, radio, and outdoor advertisements. Although spending was higher when there were more blockbusters being advertised, there are still man...
By Melissa Leonhauser Director • March 7, 2011 -
202020 VISION
Ogilvy CommonHealth Worldwide, part of the Ogilvy & Mather network and a WPP company, represents the largest assembly of creative talent in the world of healthcare communications with 64 offices across 36 countries. { For more information visit ogilvychww.com. To request the full version of t...
By David Davenport-Firth • March 7, 2011 -
SHOWCASE FEATURE: Pharma Advertising: The 3.0 Version
According to Ernst & Young’s Progressions 2011 report, in the world of Pharma 3.0, success will be based not on how many drug units are sold, but on how well pharma’s market offerings improve health outcomes, putting patients and payers at the center of the model. As part of this transition, ...
By PharmaVoice Team • March 7, 2011 -
Namaste India: Growth Across the Board
India’s importance in the pharmaceutical space is indisputable. With healthcare booming, a strong medical infrastructure, lower costs, and high levels of patient recruitment and retention, India presents enormous potential. The pharmaceutical business has been growing by 12% to 13% over the past ...
By Kim Ribbink • March 7, 2011 -
Thought Leaders
Ryan Abbate. President, Pacific Communications, a healthcare communications agency that offers strategic and tactical communications solutions. For more information, visit pacific-com.com. Edward Abrahams, Ph.D. President,The Personalized Medicine Coalition, which brings together the academ...
By PharmaVoice Team • March 7, 2011 -
Technology at the Speed of Light
The impact that the Internet and follow-on technologies have had on all areas of the life-sciences is well-documented throughout this special section, and the majority of our thought leaders have identified this as the biggest game changer in the last 10 years. Going even further, these same thou...
By PharmaVoice Team • March 7, 2011 -
The End of the Arms Race
After more than a decade of crowding physicians’ offices with as many sales reps who would fit, the pendulum has swung dramatically in the other direction. The industry’s field ranks have been reduced dramatically, and now sales reps are crowding unemployment offices. Not just a Hired Gun Terren...
By PharmaVoice Team • March 7, 2011 -
The ABCs of Marketing — Advertising, Branding, and the Customer
The ABCs of MarketingWith the introduction of DTC advertising, health information became ubiquitous, reaching consumers where they live, work, and play. “Enter technology, the Internet, place-based media, mobile devices, social media, and information now are literally available at one’s fingertip...
By PharmaVoice Team • March 7, 2011 -
R&D Innovation: The Key to Long-Term Success
When the scientific discoveries and pipeline-building process of many successful biotechs are layered together, the results are likely to be dramatic. Experts predict there will be a number of game-changing product candidates in development in the next decade. “We view ourselves as part of the ‘m...
By PharmaVoice Team • March 7, 2011 -
Around the World in 3,650 Days
Some experts say globalization will be the big story. As companies expand into new geographies to increase their revenue footprint and meet unmet healthcare needs, they will leverage talent wherever it is located to deliver solutions to markets everywhere. “The current model of serving mature mar...
By PharmaVoice Team • March 7, 2011 -
Business Not As Usual
A decade ago, our experts identified the need for pharmaceutical companies to begin to re-evaluate the business model in light of commercialization hurdles, a looming patent cliff, pipeline constrictions, mergers and acquisitions to name just a few game changers. Now, 10 years later some of these...
By PharmaVoice Team • March 7, 2011 -
A Decade of Change
During the past decade there have been tremendous advances in science, innovation, technology, communications, and patient engagement. There have also been some tremendous setbacks, including major drug recalls, intensified regulatory oversight, and let’s not forget the infamous “gas-and-go" tac...
By Taren Grom • March 7, 2011 -
Last Word
PV: What are some of the challenges facing pharmaceutical companies that technology can address? Kumar: With shrinking drug pipelines, companies are investing in better collaboration, standardization, and analytical tools to improve R&D productivity as well as their sales and marketing opera...
By PharmaVoice Team • March 3, 2011 -
Talent Pool
Pharmaceutical POOL Dr. Robert CUDDIHY Sanofi-Aventis Adds to Diabetes Team Sanofi-Aventis U.S. has appointed Robert Cuddihy, M.D., VP, medical diabetes head in the U.S. Dr. Cuddihy is responsible for developing and executing the U.S. medical affairs strategy for Sanofi-Aventis’s diabetes divisio...
By PharmaVoice Team • March 3, 2011 -
On the Calendar
March 21-22 BioConference Live: Life Sciences PharmaVOICE is exhibiting at this event. BioConference Live, bioconferencelive.com March 21-23 Digital Marketing & Communications for Canadian Pharma Toronto PharmaVOICE subscribers receive a $200 discount; register using keycode PharmaVOICE Adva...
By PharmaVoice Team • March 3, 2011 -
Social Media
Social Media Trends, Regs, and Apps Featured Briefs: Product Websites Drive Consumer Action Sidebar: Top Prescribing-Driving Sites Levitra top product website to spur consumer action Science Takes a Hit in Social Media Sanofi-Aventis Sets Ground Rules for Blogging MerckEngage Health Partnership P...
By PharmaVoice Team • March 3, 2011